CLINICA BAVIERA SA EUR0.1CC

CLINICA BAVIERA SA EUR0.1

33.0EURD
−1.0−2.94%
At close at Feb 25, 12:21 GMT
EUR
No trades
See on Supercharts

0GWJ fundamentals

Key facts

Market capitalization‪555.95 M‬EUR
Founded1992
Employees (FY)‪1.47 K‬
CEOEduardo Baviera Sabater
About

Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.

Ownership
‪‪16.30 M‬‬
Closely held shares
‪‪14.92 M‬‬ (91.5%)
Free Float shares
‪‪1.39 M‬‬ (8.5%)
Closely held shares
‪‪14.92 M‬‬ (91.5%)
Free Float shares
‪‪1.39 M‬‬ (8.5%)
Capital structure
Market cap
‪‪555.95 M‬‬
Debt
‪‪61.52 M‬‬
Minority interest
‪‪1.30 M‬‬
Cash & equivalents
‪‪32.28 M‬‬
Enterprise value
‪‪586.49 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪555.95 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
‪0.00‬
‪0.45‬
‪0.90‬
‪1.35‬
‪1.80‬
Q3 '22
Q4 '22
Q1 '23
Q1 '24
Q3 '24
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪7.0%‬
‪10.5%‬
‪14.0%‬
‪17.5%‬
‪21.0%‬
Q3 '22
Q4 '22
Q1 '23
Q1 '24
Q3 '24
‪0.00‬
‪‪17.00 M‬‬
‪‪34.00 M‬‬
‪‪51.00 M‬‬
‪‪68.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Interventions
Other
Consultations
By country
Period: 2023
Spain
Rest of Europe

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q3 '22
Q4 '22
Q1 '24
Q3 '24
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Actual
Estimate
Earnings
Next:Feb 27, 2025
2020
2021
2022
2023
2024
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
Dividend yield TTM
3.73%
Last payment
1.272
Last ex-date
Jul 16, 2024
Dividend history
‪0.0%‬
‪1.6%‬
‪3.2%‬
‪4.8%‬
‪6.4%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.35‬
‪0.70‬
‪1.05‬
‪1.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '22
Q4 '22
Q1 '23
Q1 '24
Q3 '24
‪0.00‬
‪‪16.00 M‬‬
‪‪32.00 M‬‬
‪‪48.00 M‬‬
‪‪64.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪45.00 M‬‬
‪‪90.00 M‬‬
‪‪135.00 M‬‬
‪‪180.00 M‬‬
Assets
Liabilities